MENU
+Compare
ACTU
Stock ticker: NASDAQ
AS OF
Jan 14, 04:58 PM (EDT)
Price
$5.26
Change
-$0.26 (-4.71%)
Capitalization
128.3M

ACTU Actuate Therapeutics Inc Forecast, Technical & Fundamental Analysis

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more

ACTU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACTU with price predictions
Jan 13, 2026

Momentum Indicator for ACTU turns negative, indicating new downward trend

ACTU saw its Momentum Indicator move below the 0 level on December 12, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator turned negative. In of the 32 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ACTU turned negative on December 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at .

ACTU moved below its 50-day moving average on January 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACTU crossed bearishly below the 50-day moving average on December 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACTU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACTU entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ACTU's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACTU advanced for three days, in of 69 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACTU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.737) is normal, around the industry mean (30.106). P/E Ratio (16.235) is within average values for comparable stocks, (51.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.888). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.270).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACTU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACTU is expected to report earnings to fall 16.00% to -20 cents per share on February 25

Actuate Therapeutics Inc ACTU Stock Earnings Reports
Q4'25
Est.
$-0.21
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.11
The last earnings report on December 03 showed earnings per share of -25 cents, missing the estimate of -18 cents. With 39.36K shares outstanding, the current market capitalization sits at 128.30M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKCMF84.390.02
+0.02%
Wacker Chemie AG
KROEF0.33N/A
N/A
KR1 PLC
RTGC0.50N/A
N/A
Ridder Titan Genesis Corp.
CLLNY15.51-0.52
-3.24%
Cellnex Telecom SA
CGMLF1.61-0.19
-10.34%
Chalice Mining Ltd.

ACTU and Stocks

Correlation & Price change

A.I.dvisor tells us that ACTU and SYRE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTU and SYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTU
1D Price
Change %
ACTU100%
-4.00%
SYRE - ACTU
31%
Poorly correlated
-3.87%
DSGN - ACTU
30%
Poorly correlated
+4.93%
ERAS - ACTU
29%
Poorly correlated
+20.47%
ACAD - ACTU
29%
Poorly correlated
-0.49%
PCVX - ACTU
28%
Poorly correlated
+0.39%
More